Delivery Order SPE2DB24D2100-SPE2DB25FBDTU

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,687.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, valued at $999,999,999.00. This IDC serves as a comprehensive global...
This federal contract award, valued at $1,794.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Mounjaro 10 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a firm fixed price and an ultimate completion date of April 30, 2025. This contract is not designated as a set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $1,181.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Mounjaro 7.5 mg/0.5 ml pens, a medication used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award, valued at $28,458.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 10 mg/0.5 ml pens, a medication used to treat diabetes. The contract is a delivery order, with a firm fixed price pricing type and a performance period through May 2, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,879.70 firm fixed-price delivery order is for the supply of Mounjaro 7.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of April 22, 2025. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $4,427.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a medication used in the treatment of diabetes. The contract is a Firm Fixed Price Delivery Order with a performance period ending on May 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,206.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for the DLA...
This federal contract award, valued at $1,088.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Mounjaro 15 mg/0.5 ml pens, a medication used to treat diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $4,608.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Mounjaro 10 mg/0.5 ml pens, a medication used to treat diabetes. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,448.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a firm fixed price, is for the delivery of Mounjaro 10 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of April 16, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBDTU
    Delivery Order

This federal contract award, valued at $3,950.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a medication used for the treatment of diabetes.

The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, designated as SPE2DX and valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle for the DLA, the Defense Health Agency, U.S. Coast Guard, and other government agencies, allowing AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare programs.

The contract award is not designated as a set-aside, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for fulfilling the order, with a performance period extending through April 2025.

Generated 7/23/25, 9:57 AM